Femeda Ltd Appoints Onyx Health for Launch Campaign
Femeda Ltd, a UK based healthcare company that develops medical devices to treat urinary incontinence (UI) in women, has appointed Onyx Health.
26th June 2017
OLM Diagnostics has developed a range of fungal and bacterial diagnostic tests, to fit seamlessly into current treatment pathways and reduce the rate of drug resistant infections. Onyx Health has been brought in to help develop and implement a marketing strategy to raise awareness of OLM’s diagnostic-led approach to fungal and bacterial testing.
“Having met the team, I could immediately see the value in what Onyx Health offers,” says Frazer Thompson, Operations Director at OLM Diagnostics. “They clearly know their stuff and are able to work to tight deadlines. In a short timeframe, they’ve already developed impactful messages and branding that has resonated well with our customers.”
“The North East has gained international recognition for healthcare innovation, and OLM Diagnostics is a great example of this,” says Onyx Health Director, Karen Winterhalter. “Our knowledge of the healthcare market enables us to develop and implement sales and marketing strategies to help companies navigate the complexities of global healthcare markets.”
Onyx Health work with a broad spectrum of healthcare clients, including life sciences, pharmaceutical, medical device, diagnostic and consumer health companies wanting to enter global and UK markets.